IPS Tech Talks

Video

Whether you are considering a new facility build or a facility upgrade, IPS has expert teams using the latest technologies to bring you strategies that provide cost certainty, real-time updates, and successful construction project management.

Contact us for a consultation.

Recent Videos
Industry Outlook 2025: Business Viability and Global Collaboration
Industry Outlook 2025: Business Viability and Global Collaboration
Industry Outlook 2025: Large Language Models
Industry Outlook 2025: Large Language Models
Drug Digest: Strategic Partnerships
Drug Digest: Strategic Partnerships
Ask the Expert: Product Inspection, Part Two; Automated Product Inspection and Cold Chain Considerations
Ask the Expert: Product Inspection, Part Two; Automated Product Inspection and Cold Chain Considerations
Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts
Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Industry Outlook 2025: Continuing Innovation
DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing
DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
DCAT Week 2025: Enzymatic RNA Synthesis
DCAT Week 2025: Enzymatic RNA Synthesis
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
DCAT Week 2025: Gaining End-to-End Clarity
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

FDA CBER Director Peter Marks Resigns

Susan Haigney
March 31st 2025
Article

Marks called out an ‘assault’ on truth and science in his resignation letter, which has sent the bio/pharmaceutical industry reeling.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

EMA Recommends Five New Medicines for Approval

Patrick Lavery
March 28th 2025
Article

Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Novotech Named Best Australian CRO at Asia-Pacific Biopharma Excellence Awards

Patrick Lavery
March 28th 2025
Article

Winners are selected entirely through industry voting, with those honored representing recognition by their peers.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.